| Dr Kylie Shea Rice, DO | |
|
2201 Lexington Ave, Ashland, KY 41101-2843 | |
| (606) 408-4000 | |
| Not Available |
| Full Name | Dr Kylie Shea Rice |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 4 Years |
| Location | 2201 Lexington Ave, Ashland, Kentucky |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972130540 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 05323 (Kentucky) | Secondary |
| 207R00000X | Internal Medicine | 05323 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| King's Daughters' Medical Center | Ashland, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kings Daughters Medical Specialties Inc | 6103968029 | 328 |
News Archive
The measure, dubbed the Patient Choice, Affordability, Responsibility and Empowerment Act, is being advanced by Sens. Richard Burr of North Carolina, Orrin Hatch of Utah and Tom Coburn of Oklahoma. It may provide a window into how Republicans plan to handle health reform issues in the upcoming election cycle and beyond.
Nevro Corp., a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for the treatment of chronic pain, today announced that it has received a letter from the U.S. Food and Drug Administration informing the company of the approvability of its Premarket Approval Application (PMA) for the Senza spinal cord stimulation (SCS) system.
Diabetes is characterized by elevated levels of blood sugar and is tied to various health complications. The condition is a global health issue with the number of people with diabetes increasing from 108 million in 1980 to 422 million in 2014.
Coeliac UK, the UK charity for people who need to live gluten-free, along with Innovate UK, the UK's innovation agency, have £180k available for research and are inviting applications from UK businesses and researchers.
Researchers at the Hebrew University of Jerusalem have discovered a method to potentially eliminate the tumor-risk factor in utilizing human embryonic stem cells. Their work paves the way for further progress in the promising field of stem cell therapy.
› Verified 5 days ago
| Entity Name | Southeastern Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356379382 PECOS PAC ID: 2466364997 Enrollment ID: O20050302000285 |
News Archive
The measure, dubbed the Patient Choice, Affordability, Responsibility and Empowerment Act, is being advanced by Sens. Richard Burr of North Carolina, Orrin Hatch of Utah and Tom Coburn of Oklahoma. It may provide a window into how Republicans plan to handle health reform issues in the upcoming election cycle and beyond.
Nevro Corp., a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for the treatment of chronic pain, today announced that it has received a letter from the U.S. Food and Drug Administration informing the company of the approvability of its Premarket Approval Application (PMA) for the Senza spinal cord stimulation (SCS) system.
Diabetes is characterized by elevated levels of blood sugar and is tied to various health complications. The condition is a global health issue with the number of people with diabetes increasing from 108 million in 1980 to 422 million in 2014.
Coeliac UK, the UK charity for people who need to live gluten-free, along with Innovate UK, the UK's innovation agency, have £180k available for research and are inviting applications from UK businesses and researchers.
Researchers at the Hebrew University of Jerusalem have discovered a method to potentially eliminate the tumor-risk factor in utilizing human embryonic stem cells. Their work paves the way for further progress in the promising field of stem cell therapy.
› Verified 5 days ago
| Entity Name | Kings Daughters Medical Specialties Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710215736 PECOS PAC ID: 6103968029 Enrollment ID: O20100217000538 |
News Archive
The measure, dubbed the Patient Choice, Affordability, Responsibility and Empowerment Act, is being advanced by Sens. Richard Burr of North Carolina, Orrin Hatch of Utah and Tom Coburn of Oklahoma. It may provide a window into how Republicans plan to handle health reform issues in the upcoming election cycle and beyond.
Nevro Corp., a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for the treatment of chronic pain, today announced that it has received a letter from the U.S. Food and Drug Administration informing the company of the approvability of its Premarket Approval Application (PMA) for the Senza spinal cord stimulation (SCS) system.
Diabetes is characterized by elevated levels of blood sugar and is tied to various health complications. The condition is a global health issue with the number of people with diabetes increasing from 108 million in 1980 to 422 million in 2014.
Coeliac UK, the UK charity for people who need to live gluten-free, along with Innovate UK, the UK's innovation agency, have £180k available for research and are inviting applications from UK businesses and researchers.
Researchers at the Hebrew University of Jerusalem have discovered a method to potentially eliminate the tumor-risk factor in utilizing human embryonic stem cells. Their work paves the way for further progress in the promising field of stem cell therapy.
› Verified 5 days ago
| Entity Name | Hyden Emergency Physicians, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497036776 PECOS PAC ID: 6103099163 Enrollment ID: O20111108000187 |
News Archive
The measure, dubbed the Patient Choice, Affordability, Responsibility and Empowerment Act, is being advanced by Sens. Richard Burr of North Carolina, Orrin Hatch of Utah and Tom Coburn of Oklahoma. It may provide a window into how Republicans plan to handle health reform issues in the upcoming election cycle and beyond.
Nevro Corp., a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for the treatment of chronic pain, today announced that it has received a letter from the U.S. Food and Drug Administration informing the company of the approvability of its Premarket Approval Application (PMA) for the Senza spinal cord stimulation (SCS) system.
Diabetes is characterized by elevated levels of blood sugar and is tied to various health complications. The condition is a global health issue with the number of people with diabetes increasing from 108 million in 1980 to 422 million in 2014.
Coeliac UK, the UK charity for people who need to live gluten-free, along with Innovate UK, the UK's innovation agency, have £180k available for research and are inviting applications from UK businesses and researchers.
Researchers at the Hebrew University of Jerusalem have discovered a method to potentially eliminate the tumor-risk factor in utilizing human embryonic stem cells. Their work paves the way for further progress in the promising field of stem cell therapy.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kylie Shea Rice, DO Po Box 2379, Ashland, KY 41105-2379 Ph: (606) 408-4000 | Dr Kylie Shea Rice, DO 2201 Lexington Ave, Ashland, KY 41101-2843 Ph: (606) 408-4000 |
News Archive
The measure, dubbed the Patient Choice, Affordability, Responsibility and Empowerment Act, is being advanced by Sens. Richard Burr of North Carolina, Orrin Hatch of Utah and Tom Coburn of Oklahoma. It may provide a window into how Republicans plan to handle health reform issues in the upcoming election cycle and beyond.
Nevro Corp., a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for the treatment of chronic pain, today announced that it has received a letter from the U.S. Food and Drug Administration informing the company of the approvability of its Premarket Approval Application (PMA) for the Senza spinal cord stimulation (SCS) system.
Diabetes is characterized by elevated levels of blood sugar and is tied to various health complications. The condition is a global health issue with the number of people with diabetes increasing from 108 million in 1980 to 422 million in 2014.
Coeliac UK, the UK charity for people who need to live gluten-free, along with Innovate UK, the UK's innovation agency, have £180k available for research and are inviting applications from UK businesses and researchers.
Researchers at the Hebrew University of Jerusalem have discovered a method to potentially eliminate the tumor-risk factor in utilizing human embryonic stem cells. Their work paves the way for further progress in the promising field of stem cell therapy.
› Verified 5 days ago
Padma Venkatraman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Ashland Dr, Ashland, KY 41101 Phone: 606-324-1996 Fax: 606-833-2430 | |
Amr Idris, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 613 23rd St Ste 230, Ashland, KY 41101 Phone: 606-324-4745 Fax: 606-324-4941 | |
Paula K Larsen, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1000 Ashland Dr Ste G1, Ashland, KY 41101 Phone: 606-408-4900 Fax: 606-408-6643 | |
Michael Don Canty, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 617 23rd St, Suite 11, Ashland, KY 41101 Phone: 606-324-3188 Fax: 606-329-2237 | |
Dr. Ryann Acquino Pangan, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 613 23rd St Ste 130, Ashland, KY 41101 Phone: 606-329-9335 Fax: 606-324-6383 | |
Dr. Francisco Fernandez-gonzalez, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 613 23rd St Ste 310, Ashland, KY 41101 Phone: 606-833-2161 | |
Dr. Chad Jacob Tarabolous, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 617 23rd St, Suite 19, Ashland, KY 41101 Phone: 606-325-2221 Fax: 606-324-1326 |